Answer
It is licensed as part of immunosuppressive treatment for acquired moderate to severe aplastic anaemia in specified patients who cannot receive a suitable stem-cell transplant.
Sources for this answer
- Atgam 50 mg/ml concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 3